Marijuana (Cannabis sativa) is one of the most widely used illicit drugs in the world. Its use is associated with impairments in cognitive function. We previously reported that Δ 
Introduction
The prefrontal cortex (PFC) is a set of neocortical areas involved in a variety of cognitive functions that are instrumental in working memory (WM) processing (Baddeley, 1992; D'Esposito et al, 2000; de Saint Blanquat et al, 2010) . Damage to the PFC of rodents, nonhuman primates, and humans produces profound deficits in performance on WM tasks (Passingham, 1985; Funahashi et al, 1993; Miller, 2000; Tsuchida and Fellows, 2009) . Working memory has been described as a multi-component system (Baddeley, 2003; Repovs and Baddeley, 2006) or a collection of distinct cognitive processes (Floresco and Phillips, 2001; Bunting and Cowan, 2005; Cowan, 2008 ) that provides active maintenance of trialunique information in temporary storage. In both laboratory tasks and in normal cognition, WM enables manipulation, processing, and retrieval of memories, which are converted efficiently into long-term memory after both short (seconds) and long (minutes to hours) delays (Fuster, 1997; Floresco and Phillips, 2001; Phillips et al, 2004; Funahashi, 2006; Rios Valentim et al, 2009) . During the delay period of WM tasks, brain imaging studies in humans using positron emission tomography (PET) and functional magnetic resonance imaging (fMRI) have shown increased blood flow within the PFC (Jonides et al., 1993; Petrides et al, 1993; Badre and D'Esposito, 2007) . Consistent with the increased perfusion, imaging studies have also shown higher activity of the PFC during the delay period of WM tasks (Wagner et al, 2001; Rypma, 2006; Motes and Rypma, 2010) . Thus, PFC neurons or networks seem to be equipped with a mechanism that enables them to hold active neural representations of goal-related information and to protect those representations from interfering stimuli during the delay period.
In previous studies, we demonstrated the disruptive effects on spatial working memory of the major psychoactive component of cannabis, Δ 9 -tetrahydrocannabinol (Δ 9 -THC), following both systemic administration and local injection into the medial PFC (mPFC) (Nakamura et al, 1991; Silva de Melo et al, 2005) . The impairing effects of CB1 receptor ligand Δ 9 -THC, the endogenous CB1 receptor agonist anandamide and synthetic cannabinoids on learning and on performance of diverse memory tasks in rodents (Fehr et al, 1976; Stiglick and Kalant, 1983; Nakamura et al, 1991; Brodkin and Moerschbaecher, 1997; Wise et al, 2009; Robinson et al, 2010) and nonhuman primates (Zimmerberg et al, 1971; Galbicka et al, 1980; Winsauer et al, 1999; Nakamura-Palacios et al, 2000) are well documented , but efforts are needed to better understand the mechanisms underlying that impairment.
It has long been appreciated that dopamine (DA) has a powerful influence on the cognitive functions of the PFC, including WM (Brozoski et al., 1979; Sawaguchi and GoldmanRakic, 1991; Goldman-Rakic, 1996; Zahrt et al, 1997; Lidow et al, 2003; Robbins and Arnsten, 2009) . Additionally, interactions between DA release and cannabinoids have been reported in several brain areas in vitro and in vivo (Gardner and Lowinson, 1991; Fernández-Ruiz et al, 2010) . These interactions consist in enhancement of DA release induced by cannabinoids (Poddar and Dewey, 1980; Jentsch et al., 1998; Bossong et al., 2009 ), no effect of cannabinoids over dopaminergic neurons (Szabo et al., 1999) , and inhibition of DA release (Cadogan et al., 1997) . Probably these different data are due to the variability in brain area and applied methodology, but it shows how this theme needs to be more defined.
To explore further the mechanisms by which Δ 9 -THC impairs WM, as previously reported by our laboratory, this study sought to determine if DA activation in the mPFC is directly involved in this disruption of WM induced by Δ 9 -THC. The dopamine antagonists SCH 23390 (SCH) and clozapine (CZP) were used to investigate the involvement of D 1 -like and D 2 -like dopamine receptors, respectively, on Δ 9 -THC action in the mPFC.
Results
All data presented in this study were from animals whose cannulae were successfully implanted in the mPFC. Fig. 1 shows the proper location of the bilateral cannula. Most often, the cannulae were placed in the Cg1 and Cg3 areas from the anterior cingulate and prelimbic cortex, subareas of the mPFC, especially in the 3.7-, 3.2-, and 2.7-mm sections depicted in diagrams from Paxinos and Watson (1986) . Moreover, all animals progressively improved in task performance in the radial maze. After 2 months of training, all animals achieved the baseline criterion of no more than one error in each of at least three consecutive sessions. Pre-delay task is the first step of the experiment, and as expected, animals that were trained in the radial maze until reach the criteria for experiment did not present any statistical difference in the mean of errors soon after (5 min) drugs administration. Accordingly, there is no effect on what we call reference (procedural) memory measured in the radial maze soon after Δ 9 -THC and antagonist treatment (data not shown).
Effect of the D1-like dopamine receptor antagonist SCH 23390
In the 1-h post-delay period, statistically significant difference was found among the combination of SAL with different doses of Δ 9 -THC [F(1, 16) = 11.34; p = 0.0039, ANOVA]. Animals treated with SAL followed by 100 μg Δ 9 -THC increased (p < 0.05 by Dunn's test) the mean number of errors in the radial maze task when compared to SAL followed by VEH. We assert that this result was obtained in the absence of locomotor impairment because when choice latency (i.e., the time that animals spent in each arm) was considered, there was no significant difference among all combinations (Table 1) .
To test if D 1 -like DA receptors contributed to the increase in errors made by Δ 9 -THC-treated rats, we pre-treated rats with the antagonist SCH (1 μg IC). No difference was observed between SCH and SAL pre-treatments before VEH, suggesting SCH had no effect on baseline WM (Fig. 2, first two bars) . Nevertheless, there was a significant interaction in the analysis of SCH administration prior to different doses of Δ 9 -THC [F(3, 48) = 7.11; p = 0.0005, ANOVA]. Animals treated with SCH followed by doses of 100 and 180 μg Δ 9 -THC significantly (p < 0.01, by Dunn's test) reduced the mean number of errors in the radial maze, thus preventing the impairing effect of Δ 9 -THC on WM. These results support the involvement of D1-like dopamine receptors in the disruptive effect on WM induced by Δ 9 -THC in the mPFC (Fig. 2) .
2.2.
Effect of the D2-like dopamine receptor antagonist clozapine
In the 1-h post-delay period, statistically significant difference was found among the combination of HCl with different doses of Δ -THC at doses of 32 μg (p < 0.01, by Dunn's test) and 100 (p < 0.01, by Dunn's test) administered after 0.05 N HCl elicited more errors in radial maze performance compared to 0.05 N HCl followed by VEH. The time spent in each arm was also measured, and there was no significant difference among any of the combinations ( Table 2 ), suggesting that the decrease in performance was not associated with locomotor activity impairment. To test if D 2 -like dopamine receptors participate in the disruptive effect produced by Δ 9 -THC, the antagonist CZP was administered at a dose of 3.2 μg IC prior to both VEH and all doses of Δ 9 -THC. Compared to 0.05 N HCl (VEH treatment), CZP had no effect on baseline performance ( -THC in the mPFC (Fig. 3) .
Discussion
The prefrontal cortex serves a variety of functions, including WM. Our experiments demonstrate that the impairment of spatial WM induced by intracortical injection of the exogenous cannabinoid Δ 9 -THC is prevented by the dopamine receptor antagonists SCH and CZP. Additionally, the present results also provide evidence that the cannabinoid induces disruption in spatial working memory. It was observed a different pattern in the three doses of Δ 9 -THC in the experiments with D1 or D2
antagonists. Besides the fact that the experiments are independent (different animals), the vehicle solution for the drugs was different, being SAL for SCH and HCl for CZP. This Table 1 -Locomotor activity in the SCH experiment (n = 9 rats). Time in seconds (mean ± SEM) spent by animals in each arm in the eight-arm radial maze task. There was no significant difference among the different treatment combinations. Data were analyzed using two-way ANOVA with Bonferroni post-hoc test.
Drug combinations in SCH experiment
Mean time spent ± SEM (s) -THC prevents spatial working memory impairment in the eight-arm radial maze task after a 1-h delay. Values are mean ± SEM; *p < 0.05 compared to VEH after SAL administration and ++ p < 0.01 compared to Δ 9 -THC (32, 100, or 180 μg) after SAL. Data (n = 9 rats) were analyzed using two-way ANOVA with Dunn's (Bonferroni) post-hoc test.
Table 2 -Locomotor activity in the CZP experiment (n = 10 rats). Time in seconds (±SEM) spent by animals in each arm in the eight-arm radial maze task. There was no significant difference among the different treatment combinations. Data were analyzed using two-way ANOVA with Bonferroni post-hoc test.
Drug combinations in CZP experiment
Mean time spent ± SEM (s) Administration of Δ 9 -THC significantly increased the number of errors in the radial maze task, and this finding is in accordance with published reports of Δ 9 -THC-induced spatial learning deficits in rats (Nakamura et al, 1991; Lichtman et al, 1995; Lichtman and Martin, 1996; Silva de Melo et al, 2005) . Memory impairment induced by Δ 9 -THC is mediated directly through CB 1 cannabinoid receptors (Mallet and Beninger, 1998; Varvel et al, 2001; Varvel and Lichtman, 2002) . As there is a high density of these cannabinoid receptors in the PFC (Wedzony and Chocyk, 2009; Eggan et al, 2010; Mato et al, 2010) , they probably mediate the Δ 9 -THC-induced impairment of WM in this brain area.
Briefly, the synaptic function of cannabinoids is more compatible with a modulatory role than as a classic transmitter. The frequent, although not exclusive, presynaptic location of CB 1 receptors allows cannabinoids to directly influence presynaptic events, such as the synthesis and release of specific neurotransmitters, especially γ-aminobutyric acid (GABA) and glutamate. Indeed, CB 1 receptors are frequently located on neurons containing these neurotransmitters (Lafourcade et al, 2007; Chiu et al, 2010) . The combination of numerous pharmacological, electrophysiological, and immunohistochemical studies suggest that cannabinoid receptors function as retrograde signals at the synapse, directly preventing an excess of excitation or inhibition in glutamatergic or GABAergic neurons, respectively (Schlicker and Kathmann, 2001; Piomelli, 2003; Kano et al, 2009) .
DA has been frequently linked to the action of cannabinoids within the CNS. Nevertheless, it is generally accepted that DA transmission is not the first target for the action of cannabinoid agonists; rather, the DA effects would be most likely indirect (Fattore et al, 2008; Lupica et al, 2004 ). These effects involve a variety of regulatory functions exerted by mesocorticolimbic dopaminergic neurons, such as the control of cognitive processes, learning, and memory. Considering these data and our previous results, in which we observed that activation of the CB 1 cannabinoid receptor in the PFC culminated in disruption of spatial WM (Silva de Melo et al, 2005) , we have questioned the involvement of DA receptors in this response. In the present study, DA antagonists were directly injected into the mPFC in order to assert that output DA neurons of this area would be tested. Accordingly, we found that pre-treatment with both D 1 -like and D 2 -like DA antagonists prevented the spatial WM impairment induced by Δ 9 -THC in rats, suggesting that the impairment is due to excess dopaminergic activation in the mPFC.
Since the blockade of DA receptors directly in the mPFC prevented the disruptive effect induced by Δ 9 -THC, we hypothesized in the present study that this disruption is the resultant of an excess of dopaminergic activation in the mPFC. This study provides the first evidence of dopaminergic involvement in the disruption of spatial WM after Δ 9 -THC administration into the PFC. DA release occurs in several areas of brain reward circuits after administration of Δ 9 -THC (Lupica et al, 2004) , as does an enhancement of mesolimbic DA neuron firing (Gessa et al, 1998) . However, as cited above, these effects of Δ 9 -THC over DA release are most likely indirect. The connection between DA receptor stimulation and cognitive functions has been examined systematically. An elegant study designed by Phillips et al. (2004) showed that DA efflux is elevated in the mPFC of rats after an extended delay of 30 min in a situation in which spatial memory for the correct location of food had to be recalled. The increase in DA efflux in the mPFC was not related to reward but to the accuracy of WM, confirming the correlation of this function with DA activation.
Furthermore, several other studies performed with high DA levels support the finding that excess DA release and turnover in the PFC are associated with impairment of spatial WM (Murphy et al, 1996; Zahrt et al, 1997; Seamans and Yang, 2004; Phillips et al, 2004) . Dopaminergic regulation of frontal cortical cognition was studied by Jentsch et al. (1998) , who observed that high doses of Δ 9 -THC (20 mg/kg/day for 14 days) that seemed nontoxic to mesocortical DA neurons selectively reduced PFC DA metabolism in rats.
Although the involvement of D 1 -like receptors in WM is widely recognized, recent studies have demonstrated the involvement of D 1 -and D 2 -like DA receptors on WM or executive functions in the PFC, and it has been suggested that when DA levels are high, the prefrontal network is modulated not only by D 1 but mainly by D 2 receptors (Floresco et al, 2006) . Glickstein et al. (2002) observed that mice lacking D 2 receptors show WM deficits (2002) . Additionally, systemic administration of D 2 agonists in humans improved cognitive functions, including WM and executive functions (McDowell et al, 1998) , whereas administration of D 2 antagonists impaired such functions (Mehta et al, 1999) . These findings reveal the complexity of this issue, although it is known there is an optimal level of DA activation for prime WM performance (Nieoullon, 2002; Robbins and Arnsten, 2009) .
Clozapine has antagonistic effects at a variety of transmitter receptors important for memory function, including muscarinic acetylcholinergic, serotonergic and dopaminergic receptors. Like many of the typical antipsychotic medications, clozapine acts as an antagonist at the D2 and D4 dopaminergic -THC after HCl. Data (n = 10 rats) were analyzed using two-way ANOVA with Dunn's (Bonferroni) post-hoc test.
receptors (Solanki et al., 2007) . This drug, when administered alone, has been described to impair spatial working memory and it may be associated with anticholinergic properties of clozapine rather than its action on dopamine receptors (Goldberg et al., 1993; Addy and Levin 2002; Addy et al, 2005) . In the present study, clozapine alone did not exhibit any effect in spatial working memory since the dose administered here was chosen after dose-effect curve performed exactly to exclude any possibility of drug alone effect. SCH has been widely described as a selective dopamine D1-like receptor antagonist and this is not commonly described as having effect alone over cognitive function as working memory. So, we administered SCH or CZP with no effect alone before dopaminergic activation by Δ 9 -THC and, their antagonism in D1 or D2-like DA receptor do explain the improvement in cognitive function.
Certainly, the interactions between DA, cannabinoids, and WM are complex. In addition to the fact that cannabinoids can alter DA transmission and DA-related behaviors via an indirect action on GABAergic (and glutamatergic) neurons, studies have found that cannabinoids can also activate noncannabinoid receptors, such as transient receptor potential vanilloid 1 (TRPV1), on dopaminergic neurons (Fernández-Ruiz et al., 2010) . The role of this channel in the central nervous system is widely described though poorly defined. Anandamide, AM404 or N-arachidonoyl-dopamine (NADA) are able to bind to TRPV1 (Fernández-Ruiz et al., 2010) and it is known that anandamide can exert its actions through TRPV1 cannabinoid receptor as well as CB1 (Starowicz et al., 2007) and this implies a possible cross-talk between the endovanilloid and endocannabinoid systems under either physiological or pathological conditions. We suggest that Δ 9 -THC administration, that is a CB1 ligand, may dislocate anandamide from CB1 receptor to TRPV1. This interaction deserves to be reminded in discussions about intriguing results as observed in several studies about drug abuse and neuropsychiatric disorders.
The present study provides evidence of the involvement of D 1 -like and D 2 -like DA receptors in the disruptive effect on WM of Δ 9 -THC in the PFC. Further, WM impairment induced by direct activation of the cannabinoid receptor CB 1 , but prevented by DA antagonists, might be due to dynamic signaling involving multiple components, and this interaction remains to be more defined.
4.
Experimental procedures
Subjects
Male Wistar rats (n = 19) from our own breeding colony (PPG-CF, CCS, UFES), weighing 250-300 g, were individually housed in a temperature-controlled (20-22°C) room and maintained on a 12-h light/dark cycle. The rats were food-restricted throughout the duration of the experiments to keep them at 85% of their free-feeding body weight (adjusted for growth). The care and use of all subjects in this study were conducted in agreement with the ethical principles of the Brazilian College in Animal Experimentation (COBEA, http://www. cobea.org.br), which in turn conform to international guidelines for research involving animals.
Radial arm maze
The apparatus consisted of eight symmetrical arms (70 cm long and 10 cm wide, with side walls 4 cm high), radiating from an octagonal central platform (33 cm wide). The platform was enclosed by a wall 30 cm high that served as a frame for guillotine doors at the beginning of each arm. These doors were operated by overhead strings and regulated access to each arm. As a reward, a piece of a peanut was placed in a small black cup at the end of each arm. The radial maze was made of transparent Plexiglas mounted over wood of the same shape, and it was supported by a metal structure 100 cm above the floor. The maze was kept in a constant position in the middle of a square room and illuminated by fluorescent lights. The door and a large window in the room were occluded by gray paint, and all of the other objects in the room (e.g., cabinet, rack, desk, bench, and chairs) were maintained in the same position during the experiment. All procedures in the radial maze were performed as previously described (Silva de Melo et al., 2005) . Briefly, each session was performed once a day. The animals were introduced to the apparatus and habituated to the environment and the manual handling by the experimenter. During training, the animals remained in the maze until they had entered each arm of the maze once in a given session, and training continued until the rats reached a criterion of no more than one error (re-entry into an arm previously visited during the same session) per session over three consecutive sessions (acquisition of the task). After their performance stabilized in the radial maze, the animals underwent surgery for implantation of a bilateral cannula in the mPFC.
For the delay procedure, the rats were initially allowed to enter each of four randomly pre-selected arms to get a reward, whereas access to the other four arms was blocked (pre-delay period). After obtaining the reward from each of the preselected arms, the animals were returned to their home cages for an interval of retention. After the delay period, all of the maze arms were opened, and the animals were returned to the center of the maze and allowed to complete choices to obtain rewards in the four previously obstructed arms (post-delay period). So, pre-delay is the reference (procedural) memory and after this first session performance (pre-delay), the animal may retain the information about arms already visited "online" until the performance of the second session (postdelay) that occurs one hour later (the memory that was evaluated in this study).
Cannula implantation
Rats were anesthetized with chloral hydrate (400 mg/kg, i.p.), and their heads were set in a stereotaxic apparatus (David Kopft Instruments, USA). A bilateral double cannula (2 mm long, 26 gauge; Plastics One Inc., VA, USA) was implanted at the confluence of the Cg1, Cg2, and Cg3 areas of the mPFC, according to the following parameters relative to bregma: +2.5 mm AP, ±1 mm L, and −2.0 mm V (Paxinos and Watson, 1986) . The double guide cannula was anchored to the skull with dental acrylic and four small screws and was protected with a double dummy cannula and a dust cap. Each rat was given a 5-day recovery period after surgery. Animals were then retrained in the radial arm maze to return them to their presurgery baseline performance.
Drugs and administration
An alcohol (100 vol%) stock solution of Δ 9 -THC (National Institute on Drug Abuse, Rockville, MD, USA) was stored at 4°C. For the experimental procedures, the alcohol was evaporated, and the residue was resuspended in a vehicle solution (VEH) composed of emulphor (30%) and dimethylsulfoxide at final concentrations of 64, 200, and 360 mg/ml. The volume injected was 0.5 μl, resulting in a final intracortical (IC) administration of 32, 100, and 180 μg Δ 9 -THC. Dopaminergic drugs were purchased from Sigma-Aldrich (MO, USA). The antagonist SCH 23390 [R(+)-7-chloro-8-hydroxy-3-methyl-1-phenyl-2,3,4,5-tetrahydro-1 H-3-benzazepine hydrochloride] was diluted in distilled water to 2 mg/ml, and 0.5 μl were injected, resulting in a final IC administration of 1 μg. The antagonist CZP [8-chloro-11-(4-methylpiperazin-1-yl)-5 Hdibenzo [b,e] [1,4]diazepine] was diluted in 0.05 N HCl to 6.4 mg/ml, and 0.5 μl were injected, resulting in a final IC administration of 3.2 μg. These doses of SCH and CZP were selected because previous studies in our lab had shown that they have no effect alone on radial maze performance. For control solutions, VEH alone and either saline (SAL) or HCl were administered.
To administer drugs IC to the mPFC, the dust cap and dummy cannula were removed, and a stainless steel, double internal cannula (33 gauge; Plastics One Inc.) extending to 2.7 mm was lowered through the double guide cannula to the sites of infusion. A double cannula connector (Plastics One Inc.) connected the double internal cannula to two 10-μl Hamilton syringes. A volume of 0.5 μl was delivered to each side of the mPFC over 90 s through a microprocessor syringe pump (Series 100; Stoelting, IL, USA). The experimenter gently handled subjects while the drug was administered. A 90-s diffusion period was allowed before removal of the internal cannula and replacement of the dummy cannula and the dust cap. Using this infusion procedure, animals (n = 9) bilaterally cannulated in the mPFC and well trained in the radial maze procedure first received an acute IC administration of 1 μg SCH or SAL, followed 10 min later by an acute IC administration of 32, 100, or 180 μg Δ 9 -THC or VEH. A separate cohort of animals (n = 10) received an acute IC administration of 3.2 μg CZP or 0.05 N HCl, followed 10 min later by an acute IC administration of 32, 100, or 180 μg Δ 9 -THC or VEH. Well-trained rats were then tested in the radial maze task after a 5-min interval (pre-delay task) and after 1 h (post-delay task). So, drugs were injected in well-trained rats before any testing in the maze on a test day.
The sequence of drug combinations for each animal was determined by a Latin Square schedule, which ensured that no animal repeated a given sequence of injections. A period of 7 days with no drug treatment was interposed between drug administrations, and a training session demonstrating stable responding was required prior to each drug administration.
Histology
After all experimental procedures, animals were lightly anesthetized with chloral hydrate (400 mg/kg, i.p.), and 0.5 μl (the same volume of drug administered) of a 1% methylene blue solution (Biotec, PR, Brazil) was administered IC. Afterwards, the rats were deeply anesthetized and intracardially perfused with saline followed by 4% formaldehyde. Brains were removed and maintained in 8% formaldehyde for at least 3 days. Then the brains were serially sectioned with a vibratome into slices of approximately 80 μm (Vibratome Tissue Section System, 1000 Plus, MO, USA). These slices were stained with neutral red and if cannula had been properly placed, a blue dye would be seen in the mPFC (Cg1, Cg2, Cg3 and Fr2 areas), as identified in diagrams from a rat brain atlas (Paxinos and Watson, 1986 ).
Data analysis
The number of errors and the time spent in each arm in the pre-or post-delay periods of 1-h delay tasks were expressed as the means ± SEM. Drug interactions (within Δ
9
-THC doses and between antagonist effects) were analyzed using two-way repeated-measures ANOVA followed by Dunn's (Bonferroni) correction as a post-hoc test for each pair of different groups being compared. A p-value of 0.05 or less was considered as indicative of a significant difference. The software GB-Stat Professional Statistics and either Graphics version 6.5 or GraphPad Prism 4.0 were employed for statistical analysis and graphic representation, respectively.
